暂无中文版该报道尚无中文版,以下为英文内容。低影响Biocon aims to become the world's top insulin supplier within five years, citing growing demand as Big Pharma shifts focus from the drug.Finnhub06/16 15:28相关资产3045NSEI3045 接下来的事件10/26 19:30芝加哥联储全国活动指数10/26 21:30达拉斯联储制造业指数继续探索更多 3045 新闻简报市场